Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/106572
Title: | The neurometabolic profiles of GABA and Glutamate as revealed by proton magnetic resonance spectroscopy in type 1 and type 2 diabetes | Authors: | d'Almeida, Otília C. Violante, Inês R. Quendera, Bruno Moreno, Carolina Gomes, Leonor Castelo-Branco, Miguel |
Issue Date: | 2020 | Publisher: | Public Library of Science | Project: | UID/4950/2020 CENTRO-01-0145-FEDER-000016/BIGDATIMAGE SAICTPAC/0010/2015 |
Serial title, monograph or event: | PLoS ONE | Volume: | 15 | Issue: | 10 | Abstract: | Glucose metabolism is pivotal for energy and neurotransmitter synthesis and homeostasis, particularly in Glutamate and GABA systems. In turn, the stringent control of inhibitory/excitatory tonus is known to be relevant in neuropsychiatric conditions. Glutamatergic neurotransmission dominates excitatory synaptic functions and is involved in plasticity and excitotoxicity. GABAergic neurochemistry underlies inhibition and predicts impaired psychophysical function in diabetes. It has also been associated with cognitive decline in people with diabetes. Still, the relation between metabolic homeostasis and neurotransmission remains elusive. Two 3T proton MR spectroscopy studies were independently conducted in the occipital cortex to provide insight into inhibitory/excitatory homeostasis (GABA/Glutamate) and to evaluate the impact of chronic metabolic control on the levels and regulation (as assessed by regression slopes) of the two main neurotransmitters of the CNS in type 2 diabetes (T2DM) and type 1 diabetes (T1DM). Compared to controls, participants with T2DM showed significantly lower Glutamate, and also GABA. Nevertheless, higher levels of GABA/Glx (Glutamate+Glutamine), and lower levels of Glutamate were associated with poor metabolic control in participants with T2DM. Importantly, the relationship between GABA/Glx and HbA1c found in T2DM supports a relationship between inhibitory/excitatory balance and metabolic control. Interestingly, this neurometabolic profile was undetected in T1DM. In this condition we found strong evidence for alterations in MRS surrogate measures of neuroinflammation (myo-Inositol), positively related to chronic metabolic control. Our results suggest a role for Glutamate as a global marker of T2DM and a sensitive marker of glycemic status. GABA/Glx may provide a signature of cortical metabolic state in poorly controlled patients as assessed by HbA1c levels, which indicate long-term blood Glucose control. These findings are consistent with an interplay between abnormal neurotransmission and metabolic control in particular in type 2 diabetes thereby revealing dissimilar contributions to the pathophysiology of neural dysfunction in both types of diabetes. | URI: | https://hdl.handle.net/10316/106572 | ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0240907 | Rights: | openAccess |
Appears in Collections: | FMUC Medicina - Artigos em Revistas Internacionais I&D CIBIT - Artigos em Revistas Internacionais I&D ICNAS - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
The-neurometabolic-profiles-of-GABA-and-Glutamate-as-revealed-by-proton-magnetic-resonance-spectroscopy-in-type-1-and-type-2-diabetesPLoS-ONE.pdf | 1.35 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
16
checked on Sep 2, 2024
WEB OF SCIENCETM
Citations
17
checked on Sep 2, 2024
Page view(s)
103
checked on Oct 2, 2024
Download(s)
40
checked on Oct 2, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License